ALDH2 deficiency or the ALDH2rs671 mutation can increase sensitivity to platinum-based chemotherapy in lung adenocarcinoma by increasing ferroptosis in lung adenocarcinoma tissues [98]. This evidence concerns the gene ALDH2 and lung adenocarcinoma.